JGAQX
Price
$36.36
Change
-$0.05 (-0.14%)
Updated
Jun 5 closing price
Net Assets
8.68B
RMEBX
Price
$57.64
Change
-$0.04 (-0.07%)
Updated
Jun 5 closing price
Net Assets
105.22B
Interact to see
Advertisement

JGAQX vs RMEBX

Header iconJGAQX vs RMEBX Comparison
Open Charts JGAQX vs RMEBXBanner chart's image
JPMorgan Value Advantage R2
Price$36.36
Change-$0.05 (-0.14%)
VolumeN/A
Net Assets8.68B
American Funds American Mutual R2E
Price$57.64
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets105.22B
JGAQX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JGAQX vs. RMEBX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JGAQX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 105B vs. JGAQX (8.68B). JGAQX (1.18) and RMEBX (1.16) have matching dividends . JGAQX was incepted earlier than RMEBX: JGAQX (8 years) vs RMEBX (11 years). JGAQX (1.53) is less costly to investors than RMEBX (1.07). RMEBX is a more actively managed with annual turnover of: 31.00 vs. JGAQX (17.00). JGAQX has a lower initial minimum investment than RMEBX: JGAQX (0) vs RMEBX (250). RMEBX annual gain was more profitable for investors over the last year : 8.30 vs. JGAQX (-0.04). RMEBX return over 5 years is better than : 49.85 vs. JGAQX (18.29).
JGAQXRMEBXJGAQX / RMEBX
Total Expense Ratio1.251.07117%
Annual Report Gross Expense Ratio1.531.07143%
Fund Existence8 years11 years-
Gain YTD-0.1925.349-4%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets8.68B105B8%
Annual Yield % from dividends1.181.16102%
Returns for 1 year-0.048.30-1%
Returns for 3 years-3.9717.96-22%
Returns for 5 years18.2949.8537%
Returns for 10 yearsN/A68.21-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV5.720.43
+8.22%
Verve Therapeutics
VRNT18.780.97
+5.45%
Verint Systems
CHRS0.80N/A
+0.48%
Coherus Oncology Inc
CHSCN25.15-0.05
-0.20%
CHS
PRI265.13-2.99
-1.12%
PRIMERICA